Skip to main content
. 2019 Oct 4;25(1):e138–e146. doi: 10.1634/theoncologist.2019-0395

Figure 3.

Figure 3

Overview of CRS and neurologic events. Common and serious symptoms (A) and median timing of onset and resolution (B) of CRS and neurologic events with axicabtagene ciloleucel.

Abbreviations: CAR, chimeric antigen receptor; CRS, cytokine release syndrome; HLH, hemophagocytic lymphohistiocytosis; MAS, macrophage activation syndrome.

Adapted from Journal of the Advanced Practitioner in Oncology, 10(suppl 3):21–28, S Adkins, “CAR T‐cell therapy: Adverse events and management,” Copyright 2019, with permission from Harborside 36.